DVx (TSE:3079) Cyclically Adjusted Revenue per Share: 円4,475.37 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3079 DVx Inc TSE:3079
56 GF Score
Price 円932.00
GF Value 円1,223.02
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is DVx Cyclically Adjusted Revenue per Share?

DVx TSE:3079 -0.43% 56 Cyclically Adjusted Revenue per Share is 円4,475.37 as of Mar. 2026. GuruFocus rates TSE:3079 with a GF Score™ of 56/100 and a GF Value™ of 円1,223.02 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

DVx's adjusted revenue per share for the three months ended in Mar. 2026 was 円1,352.270. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円4,475.37 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of DVx was 9.60% per year. The lowest was 6.80% per year. And the median was 9.20% per year.

As of today (2026-08-24), DVx's current stock price is 円932.00. DVx's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円4,475.37. DVx's Cyclically Adjusted PS Ratio of today is 0.21.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DVx was 0.61. The lowest was 0.21. And the median was 0.31.


DVx  (TSE:3079) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DVx's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=932.00/4475.37
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DVx was 0.61. The lowest was 0.21. And the median was 0.31.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


DVx Cyclically Adjusted Revenue per Share Related Terms


DVx Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for DVx's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DVx Cyclically Adjusted Revenue per Share Chart

DVx Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,331.76 3,677.27 3,955.30 0.00 4,475.37

DVx Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,248.77 4,321.41 4,423.95 4,475.37 0.00

TSE:3079 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, DVx's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DVx Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DVx's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DVx's Cyclically Adjusted PS Ratio falls into.


TSE:3079
56GF Score
DVx Inc TSE:3079
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DVx Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DVx's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1352.27/112.7000*112.7000
=1,352.270

Current CPI (Mar. 2026) = 112.7000.

DVx Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 694.738 98.100 798.134
201603 778.817 97.900 896.554
201606 755.032 98.100 867.402
201609 764.060 98.000 878.669
201612 788.816 98.400 903.451
201703 819.207 98.100 941.128
201706 862.166 98.500 986.458
201709 813.116 98.800 927.512
201712 874.247 99.400 991.224
201803 844.614 99.200 959.556
201806 887.863 99.200 1,008.691
201809 876.133 99.900 988.390
201812 945.665 99.700 1,068.971
201903 959.351 99.700 1,084.442
201906 1,003.500 99.800 1,133.211
201909 1,067.461 100.100 1,201.827
201912 1,107.723 100.500 1,242.193
202003 1,084.583 100.300 1,218.669
202006 839.106 99.900 946.619
202009 1,038.137 99.900 1,171.152
202012 1,081.521 99.300 1,227.466
202103 1,017.456 99.900 1,147.821
202106 1,050.032 99.500 1,189.333
202109 1,080.621 100.100 1,216.643
202112 1,153.857 100.100 1,299.098
202203 1,108.368 101.100 1,235.540
202206 1,134.465 101.800 1,255.935
202209 1,140.345 103.100 1,246.526
202212 1,144.969 104.100 1,239.558
202303 1,147.036 104.400 1,238.228
202306 1,114.250 105.200 1,193.688
202309 1,055.810 106.200 1,120.431
202312 1,111.619 106.800 1,173.029
202403 1,111.285 107.200 1,168.301
202409 0.000 108.900 0.000
202503 0.000 111.100 0.000
202506 1,303.186 111.700 1,314.853
202509 1,323.502 112.000 1,331.774
202512 1,354.837 113.000 1,351.240
202603 1,352.270 112.700 1,352.270

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円4,475.37 mean?
DVx (TSE:3079) has a Cyclically Adjusted Revenue per Share of 円4,475.37 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on DVx and its competitors.
Is DVx's Cyclically Adjusted Revenue per Share too high?
DVx's current Cyclically Adjusted Revenue per Share is 円4,475.37. Overall, DVx has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DVx's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
DVx's Cyclically Adjusted Revenue per Share of 円4,475.37 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on DVx and its competitors. DVx's current Cyclically Adjusted Revenue per Share is 円4,475.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DVx stock overvalued right now?
Based on GuruFocus' analysis, DVx (TSE:3079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,223.02, compared to a current price of 円932.00 — trading 23.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円4,475.37. DVx's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For DVx (TSE:3079), the current Cyclically Adjusted Revenue per Share is 円4,475.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DVx (TSE:3079) Overvalued in 2026?

Based on GuruFocus' analysis, DVx stock appears to be undervalued. The current stock price of 円932.00 is trading 23.8% below its estimated GF Value™ of 円1,223.02. GuruFocus considers DVx to be Modestly Undervalued.

Key valuation signals for TSE:3079:

  • Cyclically Adjusted Revenue per Share: 円4,475.37
  • GF Value™: 円1,223.02 vs. price of 円932.00 (23.8% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the TSE:3079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DVx Business Description

Address Mejiro Nakano Building, 5th Floor, 2-17-22 Takada, Toshima-ku, Tokyo, JPN, 171-0033
DVx Inc is engaged in manufacture, sale, repair, and leasing of medical equipment and related peripheral equipment, research and development of medical equipment, provide in house and out of service consulting services and services for medical and medical devices, and providing medical publication and market research.
56GF Score

Get the complete analysis for TSE:3079

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円932.00
Price
円1,223.02
GF Value